Information  X 
Enter a valid email address

Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLC

By BFN News | 09:40 AM | Thursday 14 June, 2018


Northland Capital today downgrades its investment rating on ImmuPharma PLC (LON:IMM) to corporate (from buy). Story provided by StockMarketWire.com Broker Forecasts data provided by www.sharesmagazine.co.uk

a d v e r t i s e m e n t